Inducing a mode of NK-resistance to suppression by stress and surgery: A potential approach based on low dose of poly I-C to reduce postoperative cancer metastasis

Brain, Behavior, and Immunity

Volumn 21, Issue 4, 2007, Pages 395-408

  Rosenne, Ella ^a   Shakhar, Guy ^a   Melamed, Rivka ^a   Schwartz, Yossi ^a   Erdreich Epstein, Anat ^b   Ben Eliyahu, Shamgar ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b Saban Research Institute   (United States)

Author keywords

Immunity; Metastasis; Natural killer; Poly I C; Stress; Surgery

Indexed keywords

POLYINOSINIC POLYCYTIDYLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HOST RESISTANCE; IMMUNOGENICITY; LYMPHOCYTE; MALE; METASTASIS; NATURAL KILLER T CELL; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; STRESS; SURGICAL STRESS;

ADENOCARCINOMA; ANALYSIS OF VARIANCE; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; IMMUNE TOLERANCE; INTERFERON INDUCERS; KILLER CELLS, NATURAL; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; LYMPHOMA; MALE; MICE; NEOPLASM METASTASIS; POLY I-C; POSTOPERATIVE COMPLICATIONS; RATS; RATS, INBRED F344; STRESS;

EID: 34047095585     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2006.12.002     Document Type: Article

References (59)

1. Alexopoulou L., Holt A.C., Medzhitov R., and Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413 6857 (2001) 732-738
2. Andersen B.L., Farrar W.B., Golden-Kreutz D., Kutz L.A., MacCallum R., Courtney M.E., and Glaser R. Stress and immune responses after surgical treatment for regional breast cancer. J. Natl. Cancer Inst. 90 1 (1998) 30-36
3. Avraham R., Inbar S., Rosenne E., and Ben-Eliyahu S. Autologous control of a highly malignant syngeneic CRNK-16 leukemia in the rat: a role for NK cells. Cancer Immunol. Immunother. 55 11 (2006) 1348-1357
4. Avraham, R., Schwartz, Y., Rosenne, E., Melamed, R.,Ben-Eliyahu, S. (2004). IL-12-based immunotherapy reduces post-surgery immunosuppression and metastasis, and increases survival from experimental leukemia. Paper presented at the Psychoneuroimmunology Research Society, Titisee, Germany.
5. Barlozzari T., Reynolds C.W., and Herberman R.B. In vivo role of natural killer cells: involvement of large granular lymphocytes in the clearance of tumor cells in anti-asialo GM1-treated rats. J. Immunol. 131 2 (1983) 1024-1027
6. Baxevanis C.N., Papilas K., Dedoussis G.V., Pavlis T., and Papamichail M. Abnormal cytokine serum levels correlate with impaired cellular immune responses after surgery. Clin. Immunol. Immunopathol. 71 1 (1994) 82-88
7. Ben-Eliyahu S., and Page G.G. In vivo assessment of natural killer cell activity in rats. Prog. Neuroendocrinemmunol. 5 (1992) 199-214
8. Ben-Eliyahu S., Page G.G., Yirmiya R., and Shakhar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int. J. Cancer 80 6 (1999) 880-888
9. Ben-Eliyahu S., Shakhar G., Page G.G., Stefanski V., and Shakhar K. Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines and beta-adrenoceptors. Neuroimmunomodulation 8 3 (2000) 154-164
10. Ben-Eliyahu S., Shakhar G., Rosenne E., Levinson Y., and Beilin B. Hypothermia in barbiturate-anesthetized rats suppresses natural killer cell activity and compromises resistance to tumor metastasis: a role for adrenergic mechanisms. Anesthesiology 91 3 (1999) 732-740
11. Ben-Eliyahu S., Yirmiya R., Liebeskind J.C., Taylor A.N., and Gale R.P. Stress increases metastatic spread of a mammary tumor in rats: evidence for mediation by the immune system. Brain. Behav. Immun. 5 2 (1991) 193-205
12. Davis V.L., Earp H.S., and Stempel D.A. Interferon inhibits agonist-induced cyclic AMP accumulation in human lymphocytes. Am. Rev. Respir. Dis. 130 2 (1984) 167-170
13. Di Lorenzo G., Esposito Pellitteri M., Drago A., Di Blasi P., Candore G., Balistreri C., Listi F., and Caruso C. Effects of in vitro treatment with fluticasone propionate on natural killer and lymphokine-induced killer activity in asthmatic and healthy individuals. Allergy 56 4 (2001) 323-327
14. Dokur M., Boyadjieva N., and Sarkar D.K. Catecholaminergic control of NK cell cytolytic activity regulatory factors in the spleen. J. Neuroimmunol. 151 1-2 (2004) 148-157
15. Doukas J., Cutler A.H., and Mordes J.P. Polyinosinic: polycytidylic acid is a potent activator of endothelial cells. Am. J. Pathol. 145 1 (1994) 137-147
16. Eklund J.W., and Kuzel T.M. A review of recent findings involving interleukin-2-based cancer therapy. Curr. Opin. Oncol. 16 6 (2004) 542-546
17. Ellis N.K., Duffie G.P., Young M.R., and Wepsic H.T. The effects of 16,16-dimethyl PGE2 and phosphodiesterase inhibitors on Con A blastogenic responses and NK cytotoxic activity of mouse spleen cells. J. Leukoc. Biol. 47 4 (1990) 371-377
18. Guillot L., Le Goffic R., Bloch S., Escriou N., Akira S., Chignard M., and Si-Tahar M. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J. Biol. Chem. 280 7 (2005) 5571-5580
19. Hartmann D., Schneider M.A., Lenz B.F., and Talmadge J.E. Toxicity of polyinosinic-polycytidylic acid admixed with poly-l-lysine and solubilized with carboxymethylcellulose in mice. Pathol. Immunopathol. Res. 6 1 (1987) 37-50
20. Hofer S.O., Molema G., Hermens R.A., Wanebo H.J., Reichner J.S., and Hoekstra H.J. The effect of surgical wounding on tumour development. Eur. J. Surg. Oncol. 25 3 (1999) 231-243
21. Kelsen S.G., Anakwe O., Aksoy M.O., Reddy P.J., and Dhanasekaran N. IL-1 beta alters beta-adrenergic receptor adenylyl cyclase system function in human airway epithelial cells. Am. J. Physiol. 273 3 Pt 1 (1997) L694-L700
22. Koga C., Itoh K., Aoki M., Suefuji Y., Yoshida M., Asosina S., Esaki K., and Kameyama T. Anxiety and pain suppress the natural killer cell activity in oral surgery outpatients. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 91 6 (2001) 654-658
23. Koltun W.A., Bloomer M.M., Tilberg A.F., Seaton J.F., Ilahi O., Rung G., Gifford R.M., and Kauffman Jr. G.L. Awake epidural anesthesia is associated with improved natural killer cell cytotoxicity and a reduced stress response. Am. J. Surg. 171 1 (1996) 68-73
24. Koto H., Mak J.C., Haddad E.B., Xu W.B., Salmon M., Barnes P.J., and Chung K.F. Mechanisms of impaired beta-adrenoceptor-induced airway relaxation by interleukin-1beta in vivo in the rat. J. Clin. Invest. 98 8 (1996) 1780-1787
25. Leonard J.P., Sherman M.L., Fisher G.L., Buchanan L.J., Larsen G., Atkins M.B., Sosman J.A., Dutcher J.P., Vogelzang N.J., and Ryan J.L. Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production. Blood 90 7 (1997) 2541-2548
26. Leung K.H., and Koren H.S. Regulation of human natural killing. II. Protective effect of interferon on NK cells from suppression by PGE2. J. Immunol. 129 4 (1982) 1742-1747
27. Leung K.H., and Koren H.S. Regulation of human natural killing. III. Mechanism for interferon induction of loss of susceptibility to suppression by cyclic AMP elevating agents. J. Immunol. 132 3 (1984) 1445-1450
28. Levine A.S., and Levy H.B. Phase I-II trials of poly IC stabilized with poly-l-lysine. Cancer Treat. Rep. 62 11 (1978) 1907-1912
29. Liekens S., Verbeken E., Vandeputte M., De Clercq E., and Neyts J. A novel animal model for hemangiomas: inhibition of hemangioma development by the angiogenesis inhibitor TNP-470. Cancer Res. 59 10 (1999) 2376-2383
30. Little D., Regan M., Keane R.M., and Bouchier-Hayes D. Perioperative immune modulation. Surgery 114 1 (1993) 87-91
31. Lutgendorf S.K., Cole S., Costanzo E., Bradley S., Coffin J., Jabbari S., Rainwater K., Ritchie J.M., Yang M., and Sood A.K. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin. Cancer Res. 9 12 (2003) 4514-4521
32. Malygin A.M., Meri S., and Timonen T. Regulation of natural killer cell activity by transforming growth factor-beta and prostaglandin E2. Scand. J. Immunol. 37 1 (1993) 71-76
33. Manetti R., Annunziato F., Tomasevic L., Gianno V., Parronchi P., Romagnani S., and Maggi E. Polyinosinic acid: polycytidylic acid promotes T helper type 1-specific immune responses by stimulating macrophage production of interferon-alpha and interleukin-12. Eur. J. Immunol. 25 9 (1995) 2656-2660
34. Matsumoto M., Funami K., Oshiumi H., and Seya T. Toll-like receptor 3: a link between toll-like receptor, interferon and viruses. Microbiol. Immunol. 48 3 (2004) 147-154
35. Melamed R., Rosenne E., Shakhar K., Schwartz Y., Abudarham N., and Ben-Eliyahu S. Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor. Brain. Behav. Immun. 19 2 (2005) 114-126
36. Meusel T.R., Kehoe K.E., and Imani F. Protein kinase R regulates double-stranded RNA induction of TNF-alpha but not IL-1 beta mRNA in human epithelial cells. J. Immunol. 168 12 (2002) 6429-6435
37. Mokart D., Capo C., Blache J.L., Delpero J.R., Houvenaeghel G., Martin C., and Mege J.L. Early postoperative compensatory anti-inflammatory response syndrome is associated with septic complications after major surgical trauma in patients with cancer. Br. J. Surg. 89 11 (2002) 1450-1456
38. Page G.G., Ben-Eliyahu S., and Liebeskind J.C. The role of LGL/NK cells in surgery-induced promotion of metastasis and its attenuation by morphine. Brain. Behav. Immun. 8 3 (1994) 241-250
39. Page G.G., Ben Eliyahu S., Yirmiya R., and Liebeskind J.C. Morphine attenuates surgery-induced enhancement of metastatic colonization in rats. Pain 54 1 (1993) 21-28
40. Quan N., Zhang Z., Demetrikopoulos M.K., Kitson R.P., Chambers W.H., Goldfarb R.H., and Weiss J.M. Evidence for involvement of B lymphocytes in the surveillance of lung metastasis in the rat. Cancer Res. 59 5 (1999) 1080-1089
41. Salazar A.M., Levy H.B., Ondra S., Kende M., Scherokman B., Brown D., Mena H., Martin N., Schwab K., Donovan D., Dougherty D., Pulliam M., Ippolito M., Graves M., Brown H., and Ommaya A. Long-term treatment of malignant gliomas with intramuscularly administered polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethylcellulose: an open pilot study. Neurosurgery 38 6 (1996) 1096-1104
42. Shakhar G., Bar-Ziv I., and Ben-Eliyahu S. Diurnal changes in lung tumor clearance and their relation to NK cell cytotoxicity in the blood and spleen. Int. J. Cancer 94 3 (2001) 401-406
43. Shakhar G., and Ben-Eliyahu S. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. J. Immunol. 160 7 (1998) 3251-3258
44. Shakhar G., and Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients?. Ann. Surg. Oncol. 10 8 (2003) 972-992
45. Shakhar, G., Abudarham, N., Melamed, R., Schwartz, Y., Rosenne, E., Ben-Eliyahu, S. 2006. Amelioration of operation-induced suppression of marginating pulmonary NK activity using poly IC: a potential approach to reduce post operative metastasis. Ann. Surg. Oncol. PMID 17091332 (in press).
46. Shingu K., Helfritz A., Kuhlmann S., Zielinska-Skowronek M., Jacobs R., Schmidt R.E., Pabst R., and von Horsten S. Kinetics of the early recruitment of leukocyte subsets at the sites of tumor cells in the lungs: natural killer (NK) cells rapidly attract monocytes but not lymphocytes in the surveillance of micrometastasis. Int. J. Cancer 99 1 (2002) 74-81
47. Singh M., Notterman D.A., and Metakis L. Tumor necrosis factor produces homologous desensitization of lymphocyte beta 2-adrenergic responses. Circ. Shock 39 4 (1993) 275-278
48. Sugarbaker P.H. Strategies for the prevention and treatment of peritoneal carcinomatosis from gastrointestinal cancer. Cancer Invest. 23 2 (2005) 155-172
49. Taketomi A., Shimada M., Shirabe K., Kajiyama K., Gion T., and Sugimachi K. Natural killer cell activity in patients with hepatocellular carcinoma: a new prognostic indicator after hepatectomy. Cancer 83 1 (1998) 58-63
50. Takeuchi H., Maehara Y., Tokunaga E., Koga T., Kakeji Y., and Sugimachi K. Prognostic significance of natural killer cell activity in patients with gastric carcinoma: a multivariate analysis. Am. J. Gastroenterol. 96 2 (2001) 574-578
51. Thompson J.F., Scolyer R.A., and Kefford R.F. Cutaneous melanoma. Lancet 365 9460 (2005) 687-701
52. Tsutsui S., Sonoda K., Sumiyoshi K., Kitamura K., Toh Y., Kitamura M., Kuwano H., Sugimachi K., and Okamura S. Prognostic significance of immunological parameters in patients with esophageal cancer. Hepatogastroenterology. 43 9 (1996) 501-509
53. Wadler S., Levy D., Frederickson H.L., Falkson C.I., Wang Y., Weller E., Burk R., Ho G., and Kadish A.S. A phase II trial of interleukin-12 in patients with advanced cervical cancer: clinical and immunologic correlates. Eastern Cooperative Oncology Group study E1E96. Gynecol. Oncol. 92 3 (2004) 957-964
54. Weitz J., and Herfarth C. Surgical strategies and minimal residual disease detection. Semin. Surg. Oncol. 20 4 (2001) 329-333
55. Whalen M.M., and Bankhurst A.D. Effects of beta-adrenergic receptor activation, cholera toxin and forskolin on human natural killer cell function. Biochem. J. 272 2 (1990) 327-331
56. Whitmore M.M., DeVeer M.J., Edling A., Oates R.K., Simons B., Lindner D., and Williams B.R. Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity. Cancer Res. 64 16 (2004) 5850-5860
57. Wu J., and Lanier L.L. Natural killer cells and cancer. Adv. Cancer Res. 90 (2003) 127-156
58. Yakar I., Melamed R., Shakhar G., Shakhar K., Rosenne E., Abudarham N., Page G.G., and Ben-Eliyahu S. Prostaglandin e(2) suppresses NK activity in vivo and promotes postoperative tumor metastasis in rats. Ann. Surg. Oncol. 10 4 (2003) 469-479
59. Zetter B.R. Angiogenesis and tumor metastasis. Annu. Rev. Med. 49 (1998) 407-424